Stock Research for JNJ

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

JNJ Stock Chart & Research Data

The JNJ chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the JNJ chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


JNJ Due diligence Resources & Stock Charts

The JNJ stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View JNJ Detailed Price Forecast - CNN Money CNN View JNJ Detailed Summary - Google Finance
Yahoo View JNJ Detailed Summary - Yahoo! Finance Zacks View JNJ Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View JNJ Trends & Analysis - Trade-Ideas Barrons View JNJ Major Holders - Barrons
NASDAQ View JNJ Call Transcripts - NASDAQ Seeking View JNJ Breaking News & Analysis - Seeking Alpha
Spotlight View JNJ Annual Report - CompanySpotlight.com OTC Report View JNJ OTC Short Report - OTCShortReport.com
TradeKing View JNJ Fundamentals - TradeKing Charts View JNJ SEC Filings - Bar Chart
WSJ View Historical Prices for JNJ - The WSJ Morningstar View Performance/Total Return for JNJ - Morningstar
MarketWatch View the Analyst Estimates for JNJ - MarketWatch CNBC View the Earnings History for JNJ - CNBC
StockMarketWatch View the JNJ Earnings - StockMarketWatch MacroAxis View JNJ Buy or Sell Recommendations - MacroAxis
Bullish View the JNJ Bullish Patterns - American Bulls Short Pains View JNJ Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View JNJ Stock Mentions - StockTwits PennyStocks View JNJ Stock Mentions - PennyStockTweets
Twitter View JNJ Stock Mentions - Twitter Invest Hub View JNJ Investment Forum News - Investor Hub
Yahoo View JNJ Stock Mentions - Yahoo! Message Board Seeking Alpha View JNJ Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for JNJ - SECform4.com Insider Cow View Insider Transactions for JNJ - Insider Cow
CNBC View JNJ Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for JNJ - OTC Markets
Yahoo View Insider Transactions for JNJ - Yahoo! Finance NASDAQ View Institutional Holdings for JNJ - NASDAQ


Stock Charts

FinViz View JNJ Stock Insight & Charts - FinViz.com StockCharts View JNJ Investment Charts - StockCharts.com
BarChart View JNJ Stock Overview & Charts - BarChart Trading View View JNJ User Generated Charts - Trading View


Latest Financial News for JNJ

Will Pharmaceuticals Keep Fueling J&J’s Performance in Q2 2018?
Posted on Monday July 16, 2018

The majority of Johnson & Johnson’s sales come from its pharmaceuticals division. The company also operates across medical devices and consumer business segments. In fiscal 2017, J&J generated ~50% of its total sales of $76.5 billion from its pharmaceuticals business. The trend continued in the first quarter of fiscal 2018.


Today's Research Reports on Stocks to Watch: Biocept and Johnson and Johnson
Posted on Monday July 16, 2018

NEW YORK, NY / ACCESSWIRE / July 16, 2018 / Johnson & Johnson shares saw a drop on Friday as traders reacted to last week’s court decision that the company owes $4.69 billion to 22 women over its talc-based products allegedly causing them cancer. The company is vehement on appealing the court order. Biocept shares were skyrocketing on an announcement that it has entered into an agreement with Alliance Global FZ to market and distribute liquid biopsy testing in the Middle East, Southeast Asia, and the Africa region.


The Zacks Analyst Blog Highlights: Johnson & Johnson, Novartis, UnitedHealth and Microsoft
Posted on Monday July 16, 2018

The Zacks Analyst Blog Highlights: Johnson & Johnson, Novartis, UnitedHealth and Microsoft


Johnson & Johnson: Increase in Operating Margin in Q2 2018?
Posted on Monday July 16, 2018

Johnson & Johnson (JNJ) is set to release its Q2 2018 earnings results on July 17. The company expects its pretax operating margin to expand by 150 basis points in Q2 2018, compared to a flat margin in Q1 2018, which was supported by a higher operating profit but partially offset by lower other income. In the first quarter of fiscal 2018, J&J’s cost of goods sold was down 140 basis points due to the favorable product mix and the company’s supply chain optimization initiatives.


Enter a stock symbol to view the stock details.